These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1650558)

  • 21. Prevalence of hepatitis C antibodies in clinical health-care workers.
    Zuckerman J; Clewley G; Griffiths P; Cockcroft A
    Lancet; 1994 Jun; 343(8913):1618-20. PubMed ID: 7516460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort).
    Quaranta JF; Delaney SR; Alleman S; Cassuto JP; Dellamonica P; Allain JP
    J Med Virol; 1994 Jan; 42(1):29-32. PubMed ID: 7508489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low risk of sexual transmission of hepatitis C virus in Somalia.
    Watts DM; Corwin AL; Omar MA; Hyams KC
    Trans R Soc Trop Med Hyg; 1994; 88(1):55-6. PubMed ID: 8154002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of hepatitis C antibody in Peru.
    Hyams KC; Phillips IA; Moran AY; Tejada A; Wignall FS; Escamilla J
    J Med Virol; 1992 Jun; 37(2):127-31. PubMed ID: 1378483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1.
    Corona R; Prignano G; Mele A; Gentili G; Caprilli F; Franco E; Ferrigno L; Giglio A; Titti F; Bruno C
    Epidemiol Infect; 1991 Dec; 107(3):667-72. PubMed ID: 1661241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of HBsAg, anti-HCV and anti-HDV positivity in diverse groups].
    Doğanay M; Patiroğlu T; Utaş C; Ozbakir O; Unal A; Utaş S; Aygen B; Yücesoy M
    Mikrobiyol Bul; 1993 Apr; 27(2):107-12. PubMed ID: 7684812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations.
    Huo TI; Wu JC; Wu SI; Chang AL; Lin SK; Pan CH; Huang YH; Chang FY; Lee SD
    J Med Virol; 2004 Jan; 72(1):41-5. PubMed ID: 14635009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan.
    Tanaka H; Hiyama T; Tsukuma H; Okubo Y; Yamano H; Kitada A; Fujimoto I
    Cancer Causes Control; 1994 Sep; 5(5):409-13. PubMed ID: 7999962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-HCV and recipients: situation in hemophiliacs in 1991].
    Maisonneuve P; Couroucé AM; Ferrer le Coeur F; Guérois C; Laurian Y; Magniez M; Parquet-Gernez A; Verroust F; Noël L
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):193-8. PubMed ID: 1384524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N; Hopper JL; Milner R; Breschkin AM; Bowden DS; Locarnini SA
    Eur J Epidemiol; 1994 Dec; 10(6):687-94. PubMed ID: 7672048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serological investigation on intrafamilial transmission of HCV infection].
    Wang S; Huang Y; Yu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Feb; 15(1):34-7. PubMed ID: 7521795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients.
    Ayoola EA; Huraib S; Arif M; al-Faleh FZ; al-Rashed R; Ramia S; al-Mofleh IA; Abu-Aisha H
    J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low prevalence of anti-HCV antibodies in hospital workers.
    Stellini R; Calzini AS; Gussago A; Rodella A; Signorini A
    Eur J Epidemiol; 1993 Nov; 9(6):674-5. PubMed ID: 7512052
    [No Abstract]   [Full Text] [Related]  

  • 38. Tattooing as a risk of hepatitis C virus infection.
    Ko YC; Ho MS; Chiang TA; Chang SJ; Chang PY
    J Med Virol; 1992 Dec; 38(4):288-91. PubMed ID: 1282147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of a relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique.
    Dazza MC; Meneses LV; Girard PM; Astagneau P; Villaroel C; Delaporte E; Larouze B
    Am J Trop Med Hyg; 1993 Feb; 48(2):237-42. PubMed ID: 8383469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.